Ex-SAC Trader Martoma Floored Doctor With His Knowledge – ValueWalk Premium
SAC Capital Advisors
16Jan

Ex-SAC Trader Martoma Floored Doctor With His Knowledge

A doctor testifying in the insider trading trial of former Ex-SAC trader Martoma said that he was flabbergasted that the trader appeared to already know results from a drug trial.

Joel Ross, a New Jersey doctor, told jurors in federal court that Martoma quoted ‘exact numbers’ to him during a 2008 meeting.
Martoma accused of using insider information
Martoma, a former manager at SAC’s Intrinsic unit, is

SORRY!

This content is exclusively for paying members.

If you are subscribed and having an account error please clear cache and cookies if that does not work email [email protected] or click Chat.

Author

Mani is a Senior Financial Consultant. He has worked in Senior Management role in large banking, financial and information technology organizations. He has provided solutions for major banking and securities firms across the globe in the area of retail, corporate and investment banking. He holds MBA (Finance) and Professional Management Accounting Qualifications. His hobbies are tracking global financial developments and watching sports

Related Posts

art market revenue by country

Is A Bubble Forming In The Art Market?

Mar

As some hedge fund traders are labeling the stimulus-dependent stock market a “bubble,” could another bubble be forming in the fine art market? "Best year ever" in art In 2013 the... Read More

high frequency trading

The High Frequency Trading Tactic That Reduces Market Liquidity

Jun

The two arguments you typically hear in defense of high frequency trading are that it improves price discovery and supplies market liquidity, which has at least some backing in... Read More

Odey Adds 14.8% YTD, Sees Plenty Of Value In Europe

Jul

In March, Odey Asset Management rebranded most of its investment funds under its newly created Brook Asset Management subsidiary. The firm announced the rebrand in November. Odey AM revealed that... Read More

Intel Earnings $0.53 Per Share On Q1

Apr

Intel Corporation (NASDAQ:INTC) announced its earnings for the first quarter of 2012 today after the market closed. The company announced earnings of $0.53 per share for the period. Analysts had... Read More

China Will Have A ‘Long Landing,’ Says Pettis

Sep

The debate over whether China is going to experience a hard or soft landing is likely to last for a few more years as the country transitions away from... Read More

Industry exposure

Horseman Global Fund Still Says “Short Equities, Long Bonds” After Rough April

May

In its April letter, Horseman Global Fund Ltd notes that the overwhelming theme of the market for the past 18 months or so has been that of a strong... Read More

Acer CEO Quits On The Heels Of $446 Million Q3 Loss

Nov

Acer Incorporated (TPE:2353) reported its earnings for the third quarter of 2013 this morning before the market opened on Wall Street. The Taiwanese PC maker showed a loss of... Read More

Mutual Fund

European Funds Still Attractive With 1/3 Of World's Investable Assets

Jul

In a recent report, Stifel Nicolaus Equity Research noted European mutual funds saw long-term flows turn negative as volatility and interest rate concerns in the U.S. spilled into the global... Read More

Israel

Israel Moves Up The Activist Agenda (Long And Short)

Aug

Activists publicly targeted 12 Israel-headquartered companies in the past 18 months, as many as in the previous three years. The maturing Israeli stock market has led to an influx of... Read More

Sovereign Ratings

Moody’s Warns Of Sovereign Debt Dangers As Political And Economic Risks Increase

Nov

High debt, low growth and political curveballs might have plunged the outlook for the world economy to its worst in four years and one of the biggest worries is... Read More

X
Saved Articles
X
TextTExtLInkTextTExtLInk
0